Biblio

Export 3292 results:
Author Title [ Type(Asc)] Year
Journal Article
J. Denner, Tanzi, R., and Jacobson, S., “Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus.”, J Alzheimers Dis, vol. 77, no. 2, pp. 543-545, 2020.
P. Gavin Kehoe, Hibbs, E., Palmer, L. E., and J Miners, S., “Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.”, J Alzheimers Dis, vol. 58, no. 1, pp. 203-214, 2017.
S. Yasar, Moored, K. D., Adam, A., Zabel, F., Chuang, Y. - F., Varma, V. R., and Carlson, M. C., “Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 75, no. 2, pp. 521-529, 2020.
C. Zhang, Zhang, Y., Shen, Y., Zhao, G., Xie, Z., and Dong, Y., “Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer's Disease Transgenic Mice.”, J Alzheimers Dis, vol. 57, no. 2, pp. 505-518, 2017.
H. - B. Kim, Park, B., and Shim, J. - Y., “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
S. Bagewadi Kawalia, Raschka, T., Naz, M., Simoes, Rde Matos, Senger, P., and Hofmann-Apitius, M., “Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1237-1254, 2017.
B. A. Ardekani, Convit, A., and Bachman, A. H., “Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
B. K. Binukumar, Shukla, V., Amin, N. D., Bhaskar, M., Skuntz, S., Steiner, J., Winkler, D., Pelech, S. L., and Pant, H. C., “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
M. Narukawa, Takahashi, S., Saito, T., Saido, T. C., and Misaka, T., “Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 997-1004, 2020.
M. Jeong Wang, Yi, S. H., Han, J. - Y., Park, S. Young, Jang, J. - W., Chun, I. Kook, Van Giau, V., Bagyinszky, E., Lim, K. Taek, Kang, S. Min, An, S. Soo A., Park, Y. Ho, Youn, Y. Chul, and Kim, S. Y., “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
H. Zhang, Chen, K., Wang, N., Zhang, D., Yang, Q., Zhang, Q., Liu, P., Wan, M., Gong, C., Hong, X., Qiu, W., Qian, X., Chen, Y., and Ma, C., “Analysis of Brain Donors' Demographic and Medical Characteristics to Facilitate the Construction of a Human Brain Bank in China.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1245-1254, 2018.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., “Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.”, J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
L. - J. Zuo, Guo, P., Liu, L., Yu, S. - Y., Lian, T. - H., Yu, Q. - J., Hu, Y., Jin, Z., Wang, R. - D., Piao, Y. - S., Li, L. - X., Wang, Y. - J., Wang, X. - M., and Zhang, W., “Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction.”, J Alzheimers Dis, vol. 66, no. 2, pp. 789-799, 2018.
P. H. Nguyen, Del Castillo-Frias, M. P., Berthoumieux, O., Faller, P., Doig, A. J., and Derreumaux, P., “Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based Assays.”, J Alzheimers Dis, vol. 64, no. s1, pp. S659-S672, 2018.
N. Liu, Yu, Z., Xun, Y., Shu, P., Yue, Y., Yuan, S., Jiang, Y., Huang, Z., Yang, X., Feng, X., Xiang, S., and Wang, X., “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
M. Abdullah, Takase, H., Nunome, M., Enomoto, H., Ito, J. - I., Gong, J. - S., and Michikawa, M., “Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
I. Ferrer, “Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.”, J Alzheimers Dis, vol. 100, no. s1, pp. S153-S164, 2024.
E. N. Cline, Bicca, M. Assunção, Viola, K. L., and Klein, W. L., “The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S567-S610, 2018.
Y. Zhang, Guo, O., Huo, Y., Wang, G., and Man, H. - Y., “Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1789-1801, 2018.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
T. Daly, Houot, M., Barberousse, A., Agid, Y., and Epelbaum, S., “Amyloid-β in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1309-1317, 2020.
S. Hatashita and Wakebe, D., “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
D. D. Quintana, Garcia, J. A., Anantula, Y., Rellick, S. L., Engler-Chiurazzi, E. B., Sarkar, S. N., Brown, C. M., and Simpkins, J. W., “Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.”, J Alzheimers Dis, vol. 75, no. 1, pp. 119-138, 2020.
R. M. Nisbet and Götz, J., “Amyloid-β and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies.”, J Alzheimers Dis, vol. 64, no. s1, pp. S517-S527, 2018.

Pages